MILESTONE AND ROYALTY BUY-OUT AGREEMENTMilestone and Royalty Buy-Out Agreement • September 11th, 2018 • Xenon Pharmaceuticals Inc. • Pharmaceutical preparations
This Milestone and Royalty Buy-Out Agreement (this “Agreement”) is entered into as of this 7th day of September, 2018, by and between Xenon Pharmaceuticals Inc. (hereinafter “Xenon”), Valeant Pharmaceuticals Ireland Limited (hereinafter “VPIL”) and Valeant Pharmaceuticals Luxembourg S.a.r.l. (hereinafter “VPL”), each referred to herein individually as a “Party,” and collectively as the “Parties.”
